Form D · Other Health Care
CytoAgents, Inc.
Pittsburgh, PA · CIK 0001877258
Offering snapshot reported May 16, 2023 · SEC filing
- Reported sold
- $7M Offering amount: $15.2M
- Investors reported
- 23 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 3, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 16, 2023 | Initial | $7,003,238 | No comparison | 23 | SEC filing |
| Aug 12, 2021 | Initial | $6,106,500 | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-481794
$8.91 of the Total Offering Amount and Total Amount Sold includes the exercise price due upon the exercise of a Warrant into equity of the Issuer.
Source: Form D, filed May 16, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Robert L Ferris | Director |
| John Friedman | Director |
| Stanley Marks | Director |
| Anthony Mc Carley | Director |
| Catherine Mott | Director |
| Roy Prieb | Executive |
| Teresa Whalen | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
100 S Commons #102
Pittsburgh, PA, 15212
Pittsburgh, PA, 15212